Opill Tablet
Product Images NDC 0113-8101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Opill (NDC 0113-8101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by L. Perrigo Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Clock (Image 01)

Clock (Image 01)
FDA Label Image

Condom (Image 02)

Condom (Image 02)
FDA Label Image

Female-outline (Image 03)

Female-outline (Image 03)
This text discusses a type of contraceptive method that works by preventing sperm from reaching the egg. It achieves this by thickening the cervical mucus.*
FDA Label Image

Tier-one (Image 04)

Tier-one (Image 04)
FDA Label Image

Tier-two (Image 05)

Tier-two (Image 05)
FDA Label Image

Tiers (Image 06)

Tiers (Image 06)
This text is not-readable.*
FDA Label Image

Opill-pdp (Image 07)

Opill-pdp (Image 07)
FDA Label Image

Opill-dfl-one (Image 08)

Opill-dfl-one (Image 08)
This is an evaluation of Opill, a daily oral contraceptive containing Norgestrel tablets 0.075mg. It is used to prevent pregnancy but does not protect against HIV/AIDS or STDs. The drug facts include warnings about allergic reactions, changes in menstrual periods, and possible side effects like headaches and nausea. It advises not to use if pregnant, have breast cancer, or suspect pregnancy. It also provides directions on how to take the tablets daily for maximum effectiveness in preventing pregnancy, including using additional protection during the first two days of use. It recommends seeking medical help for specific issues and interactions with other medications.*
FDA Label Image

Opill-dfl-two (Image 09)

Opill-dfl-two (Image 09)
This is not-readable.*
FDA Label Image

Reminder-card-front (Image 10)

Reminder-card-front (Image 10)
This text provides important instructions for taking a tablet daily for contraception. It emphasizes the importance of consistency, even during changes in the menstrual cycle, and the need for backup contraception if a tablet is missed or late. It advises referencing the Drug Facts and consumer information leaflet for additional details.*
FDA Label Image

Reminder-card-back (Image 11)

Reminder-card-back (Image 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.